Dr. Allison Michelle Andrews' lab focuses on understanding the intersection of synthetic opioids, particularly fentanyls, and HIV, especially in the brain. Researchers investigate how fentanyls affect the blood-brain barrier and contribute to HIV replication, while also developing innovative imaging techniques to study HIV reservoirs in the central nervous system (CNS). The aim is to better comprehend how these factors interact and impact health, especially for people living with HIV.

Dr. Weizhou Zhang's lab at the University of Florida researches innovative cancer therapies that focus on developing new drugs that can dismantle cancer cells while also harnessing the body's immune system. They specifically use a technology called Proteolysis-targeting chimera (PROTAC) to target and degrade specific proteins involved in cancer, particularly in melanoma, renal cell carcinoma, and breast cancer metastasis. The lab's work aims to improve cancer treatment outcomes by addressing both tumor cells and the immune environment.

Dr. Mark A. Atkinson's lab focuses on understanding how the pancreas changes during the progression of type 1 diabetes (T1D). The research explores how both immune responses and changes within pancreas cells lead to the disease. By studying human pancreas samples, the lab aims to identify specific molecular pathways and potential treatments to improve pancreatic function and prevent T1D progression.

Dr. Daniel Swale's lab at the University of Florida studies how potassium channels influence the immune response to viruses. By examining these channels in various organisms, including insects and mammals, the research aims to uncover how potassium levels affect antiviral responses and could inform new therapeutic strategies. The lab will explore the connections between ion channels, immune function, and viral replication, contributing to a better understanding of viral infections and potential interventions.

Dr. Stefan Prokop's lab at the University of Florida focuses on understanding how certain proteins in the brain contribute to Alzheimer's disease (AD). They are investigating the role of amyloid-associated proteins (AAPs) in the progression of the disease, particularly how these proteins might affect neurodegeneration over time. By studying these processes, the lab aims to identify potential new therapeutic targets to combat AD and improve patient outcomes.

Dr. Marco Salemi's lab focuses on understanding how SARS-CoV-2 evolves in people with compromised immune systems, specifically those with HIV. They develop advanced computational tools using artificial intelligence to predict which viral variants might emerge and spread. This research is crucial for improving public health responses to ongoing and future COVID-19 challenges.